The Impact of Differences in Surveillance Definitions of Hospital Acquired Urinary Tract Infections (HAUTI).

HAI HAUTI infection control nosocomial infections surveillance

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
18 Oct 2021
Historique:
received: 21 09 2021
revised: 14 10 2021
accepted: 15 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Hospital-acquired urinary tract infections (HAUTI) are common and most cases are related to catheters (CAUTI). HAUTI and CAUTI surveillance is mandatory in many countries as a measure to reduce the incidence of infections and appropriately direct the allocation of preventable resources. The surveillance criteria issued by the Israeli Ministry of Health (IMOH), differ somewhat from that of the U.S. Centers for Disease Control and Prevention (CDC). Our study aims were to query and quantify the impact of these differences. In a retrospective cohort study conducted at Shamir Medical Center, for calendar year 2017, the surveillance criteria of both IMOH and CDC were applied on 644 patient-unique adults with "positive" urine cultures (per similar definitions). The incidence of HAUTI per IMOH was significantly higher compared to CDC (1.24/1000 vs. 1.02/1000 patient-days,

Identifiants

pubmed: 34680842
pii: antibiotics10101262
doi: 10.3390/antibiotics10101262
pmc: PMC8532618
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Infect Control Hosp Epidemiol. 2011 Feb;32(2):101-14
pubmed: 21460463
J Hosp Infect. 2007 Jul;66(3):243-8
pubmed: 17574304
Clin Infect Dis. 2009 May 1;48(9):1268-75
pubmed: 19335166
Infect Control Hosp Epidemiol. 2021 Jan;42(1):37-42
pubmed: 32787996
Future Microbiol. 2017 Mar;12:271-283
pubmed: 28287300
CMAJ. 2017 Sep 5;189(35):E1115
pubmed: 28874433
Antimicrob Resist Infect Control. 2021 Jun 4;10(1):87
pubmed: 34088341
J Hosp Infect. 2008 Jul;69(3):230-48
pubmed: 18550218
Infect Dis Clin North Am. 2014 Mar;28(1):105-19
pubmed: 24484578
Am J Infect Control. 2020 Apr;48(4):423-432
pubmed: 31676155
Am J Infect Control. 2012 May;40(4):359-64
pubmed: 21868133
Ann Intern Med. 2009 Jun 16;150(12):877-84
pubmed: 19528567
Top Spinal Cord Inj Rehabil. 2019 Summer;25(3):228-240
pubmed: 31548790

Auteurs

Yossef Levi (Y)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.

Debby Ben-David (D)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Unit of Infection Control, Wolfson Medical Center, Holon 5822012, Israel.

Inna Estrin (I)

Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Hodaya Saadon (H)

Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Maya Krocker (M)

Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Lili Goldstein (L)

Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Dan Klafter (D)

Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Shani Zilberman-Itskovich (S)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Dror Marchaim (D)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin 7030000, Israel.

Classifications MeSH